Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synaptic Institute is a healthcare education and training organization based in Portland, Oregon, specializing in psychedelic-assisted therapy. The institute offers a state-approved curriculum designed to train facilitators for Oregon's regulated psilocybin services market under Measure 109. Their programs integrate clinical research, neuroscience, and traditional practices to provide a holistic approach to mental health treatment. Synaptic Institute also serves as a community hub for practitioners and researchers interested in the therapeutic potential of entheogens. The organization is focused on expanding access to safe and ethical psychedelic care through professional development and public education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synaptic Institute.